STARGAZER PHARMACEUTICALS
Stargazer Pharmaceuticals is a pharmaceutical company that offers the therapy of standards disorder and manufacturer of pharmaceuticals products. It's also a Manufacturer of pharmaceuticals. The company is currently operating in Stealth mode.
STARGAZER PHARMACEUTICALS
Industry:
Manufacturing Pharmaceutical
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.stargazerpharmaceuticals.com
Total Employee:
1+
Status:
Active
Total Funding:
94.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Amazon AdBlock Acceptable Ads Liquid Web Bodis ParkLogic DNS
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Berkshire Welco
Berkshire Welco focuses on the cultivation, manufacturing, and retailing of recreational marijuana.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
MAIA Pharmaceuticals
MAIA Pharmaceuticals identifies, develops, manufactures and markets innovative and niche generic products.
Multiply Labs
Multiply Labs deploys advanced robotics technology to manufacture personalized pharmaceutical capsules.
ProTom International
ProTom International is a leading device manufacturer of proton therapy technology.
Silk Therapeutics
Silk Therapeutics is a biotech company that offers skincare products for human health and wellness.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Zhenge Biotech
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Current Advisors List
Current Employees Featured
Founder
Investors List
venBio Partners
venBio Partners investment in Series A - Stargazer Pharmaceuticals
Retinal Degeneration Fund
Retinal Degeneration Fund investment in Series A - Stargazer Pharmaceuticals
Canaan Partners
Canaan Partners investment in Series A - Stargazer Pharmaceuticals
Pontifax
Pontifax investment in Series A - Stargazer Pharmaceuticals
Novo Holdings
Novo Holdings investment in Series A - Stargazer Pharmaceuticals
Official Site Inspections
http://www.stargazerpharmaceuticals.com
- Host name: haproxy05.parklogic.com
- IP address: 69.16.230.165
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Stargazer Pharmaceuticals"
Stargazer Pharmaceuticals - Crunchbase Company Profile & Funding
Stargazer Pharmaceuticals is a pharmaceutical company that offers the therapy of standards disorder and manufacturer of pharmaceuticals products.See details»
Stargazer Pharmaceuticals - PitchBook
Stargazer Pharmaceuticals General Information Description. Developer of biopharmaceutical drugs intended to focus on rare diseases of the eye. The company is focused on the development of a novel treatment option for …See details»
Stargazer Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Stargazer Pharmaceuticals, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Stargazer Pharmaceuticals Company Profile | Management and
Www.stargazerpharmaceuticals.com Stargazer Pharmaceuticals Profile and History Stargazer Pharmaceuticals Inc is an ophthalmic biotech company focused on the development of a novel …See details»
Stargazer Pharmaceuticals, Inc. (Stargazer Pharmaceuticals, Inc.)
LUND, SWEDEN / ACCESSWIRE / June 16, 2022 / BioInvent International AB ("BioInvent") (NASDAQ Stockholm:BINV), a biotech company focused on the discovery and development of …See details»
Stargazer Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
View Stargazer Pharmaceuticals (www.stargazerpharmaceuticals.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Stargazer Pharmaceuticals - Products, Competitors, Financials ...
Stargazerpharmaceuticals.com. Overview & Products; Financials; People; Alternatives & Competitors; Founded Year 2018. Stage Series A | Alive. Total Raised $85.46M. Last Raised …See details»
Novo Holdings · News & Reports · novo-ventures-incubated-rare …
Nov 9, 2020 Stargazer Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel treatment options for rare eye diseases, announced it has completed a …See details»
Nextsource | Company Profile | Stargazer Pharmaceuticals
Explore the company profile of Stargazer Pharmaceuticals (stargazerpharmaceuticals.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Stargazer Pharmaceuticals, Inc.:Company Profile & Technical …
Stargazer Pharmaceuticals is a company that provides Medicine, Stargardt's disease, Retinal degeneration and more. Stargazer Pharmaceuticals is headquartered in United States …See details»
Stargazer Pharmaceuticals - VentureRadar
"Stargazer Pharmaceuticals Inc is an ophthalmic biotech company focused on the development of a novel treatment option for Stargardt Disease, a genetic orphan retinal disease with …See details»
Stargazer Pharmaceuticals Inc. Asset Profile | Preqin
Founded in 2018 and based in Massachusetts, US, operates as a biopharmaceutical company that focuses on treating rare eye diseases.See details»
Stargazer Pharmaceuticals, Inc. Announces $57 Million Series A
BOSTON, Nov. 9, 2020 /PRNewswire-PRWeb/ -- Stargazer Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel treatment options for rare …See details»
Stargazer Pharmaceuticals | CipherBio
Explore Stargazer Pharmaceuticals's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
News - Retinal Degeneration) Fund
November, 09 2020 • Articles. Stargazer Pharmaceuticals, Inc. Announces $57 Million Series A Financing and Initiation of a Phase 2a Clinical Study of STG-001 in Stargardt Disease PatientsSee details»
Stargazer Pharmaceuticals Initiates a Phase 2a Clinical Trial for its ...
Nov 9, 2020 The Foundation Fighting Blindness is a qualified 501(c)(3) non-profit organization and all donations are tax deductible. EIN 23-7135845. ...See details»
Stargazer Pharmaceuticals - CB Insights
Generation Bio. Generation Bio (NASDAQ: GBIO) innovates genetic medicines to provide treatment for diseases. Its platform incorporates a novel Deoxyribonucleic acid (DNA) …See details»
Wilson Sonsini Advises Stargazer Pharmaceuticals in $57 Million …
On November 9, 2020, Stargazer Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel treatment options for rare eye diseases, announced it has …See details»
Stargazer Pharmaceuticals Raises $57 Million for Rare Eye Disease ...
Nov 10, 2020 Rare Daily Staff. Stargazer Pharmaceuticals completed a $57 million Series A financing to advance development of novel treatments for rare eye diseases.See details»
Stargazer Pharmaceuticals, Inc. Announces $57 Million Series A ...
Nov 10, 2020 Financing will enable Stargazer to advance development of STG-001 through a pivotal clinical study in Stargardt Disease. BOSTON, MA, USA I November 09, 2020 I …See details»